Hogan Lovells 2024 Election Impact and Congressional Outlook Report
Webinar | 14 December 2023 | 10:30 AM - 12:00 PM (JST)
In this 22nd session, we will cover recent developments, risks and risk mitigation in U.S. “Hatch-Waxman” patent litigation (U.S. Life Sciences patent litigation between originator and generic companies under the U.S. Drug Price Competition and Patent Term Restoration Act) and associated regulatory issues with Dr Frederick Ch'en, David M. Fox, Howard W Levine and Jennifer Swan from a practical, strategic and comparative perspective.
There will be a question-and-answer period and you will be able to submit questions online during the session. If you would like to send questions in advance (in Japanese or English), please contact [email protected].
We very much look forward to your attendance.